Understanding how a specific RNA helps the immune system fight herpesvirus infections
Novel Role for Host Immunostimulatory RNA in Antiviral Immune Defense
This study is looking at how a special RNA molecule can help boost the immune system's fight against the herpes virus, and if you're interested, you might be able to help by sharing samples or joining in on related research.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10906948 on NIH RePORTER |
What this research studies
This research investigates the role of a particular RNA molecule, RNA5SP141, in enhancing the immune response against herpes simplex virus type 1 (HSV-1). By using advanced techniques like CRISPR gene editing, the study aims to uncover how this RNA activates immune sensors in the body to trigger a stronger antiviral defense. The research will also explore how this RNA is transferred between infected and uninfected cells, potentially influencing the immune response. Patients may be able to contribute to this research by providing samples or participating in related studies.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals with a history of herpes simplex virus infections or those experiencing severe HSV-1 related complications.
Not a fit: Patients who do not have herpesvirus infections or related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for enhancing antiviral immunity, particularly for patients suffering from herpesvirus infections.
How similar studies have performed: Previous research has shown promising results in understanding immune responses to viral infections, making this approach both relevant and potentially impactful.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Gack, Michaela Ulrike — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Gack, Michaela Ulrike
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.